Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
200670.KQ Stock Summary
Top 10 Correlated ETFs
200670.KQ
In the News
200670.KQ Financial details
Company Rating
Buy
Market Cap
311.33B
Income
24.82B
Revenue
152.27B
Book val./share
19053.66
Cash/share
7719.79
Dividend
-
Dividend %
-
Employees
226
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
34.39
Forward P/E
6.87
PEG
29.72
P/S
2869.36
P/B
2.47
P/C
3.79
P/FCF
58529.88
Quick Ratio
1.98
Current Ratio
3.06
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
2.54K
EPS next Y
4256.5
EPS next Q
924
EPS this Y
10.48%
EPS next Y
67.78%
EPS next 5Y
67.78%
EPS last 5Y
18.09%
Revenue last 5Y
14.14%
Revenue Q/Q
-7.36%
EPS Q/Q
-55.83%
-
-
-
-
SMA20
1.77%
SMA50
-10.01%
SMA100
-15.53%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
7%
ROC
0.09%
Gross Margin
40%
Oper. Margin
14%
Profit Margin
8%
Payout
42%
Shs Outstand
10.39M
Shs Float
5.72M
-
-
-
-
Target Price
-
52W Range
22500.0-44500.0
52W High
-34.27%
52W Low
+30%
RSI
52.73
Rel Volume
0.51
Avg Volume
81.9K
Volume
41.75K
Perf Week
1.39%
Perf Month
-0.68%
Perf Quarter
-19.86%
Perf Half Y
-16.43%
-
-
-
-
Beta
0.601
-
-
Volatility
366.45%, 764.67%
Prev Close
-0.85%
Price
29250
Change
0%
200670.KQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.25K | 10.36K | 11.8K | 13.28K | 15.41K | |
Net income per share | 1.09K | 1.59K | 963.99 | 2.27K | 2.51K | |
Operating cash flow per share | 1.45K | 2.5K | 2.04K | 4.11K | 3.13K | |
Free cash flow per share | 469.13 | 638.7 | 472.31 | 3.33K | 2.21K | |
Cash per share | 2K | 4.59K | 5.78K | 9.78K | 8.12K | |
Book value per share | 11.77K | 12.63K | 13.4K | 15K | 20.05K | |
Tangible book value per share | 12.74K | 13.96K | 15.1K | 14.67K | 20.05K | |
Share holders equity per share | 11.77K | 12.63K | 13.4K | 15K | 20.05K | |
Interest debt per share | 166.48 | 2.24K | 3.93K | 4.59K | 1.01K | |
Market cap | 220.53B | 225.72B | 225.21B | 256.88B | 319.63B | |
Enterprise value | 203.16B | 218.12B | 248.59B | 201.81B | 242.09B | |
P/E ratio | 21.16 | 14.96 | 24.84 | 12.18 | 12.88 | |
Price to sales ratio | 2.81 | 2.29 | 2.03 | 2.09 | 2.1 | |
POCF ratio | 15.97 | 9.5 | 11.74 | 6.73 | 10.35 | |
PFCF ratio | 49.35 | 37.19 | 50.71 | 8.32 | 14.62 | |
P/B Ratio | 1.97 | 1.88 | 1.79 | 1.85 | 1.61 | |
PTB ratio | 1.97 | 1.88 | 1.79 | 1.85 | 1.61 | |
EV to sales | 2.58 | 2.21 | 2.24 | 1.64 | 1.59 | |
Enterprise value over EBITDA | 9.31 | 8.09 | 9 | 5.5 | 5.01 | |
EV to operating cash flow | 14.71 | 9.18 | 12.96 | 5.29 | 7.84 | |
EV to free cash flow | 45.46 | 35.93 | 55.97 | 6.54 | 11.08 | |
Earnings yield | 0.05 | 0.07 | 0.04 | 0.08 | 0.08 | |
Free cash flow yield | 0.02 | 0.03 | 0.02 | 0.12 | 0.07 | |
Debt to equity | 0.01 | 0.18 | 0.24 | 0.24 | 0 | |
Debt to assets | 0.01 | 0.12 | 0.14 | 0.15 | 0 | |
Net debt to EBITDA | -0.8 | -0.28 | 0.85 | -1.5 | -1.61 | |
Current ratio | 3.38 | 2.38 | 3.28 | 1.66 | 6.65 | |
Interest coverage | 291.26 | 63.91 | 2.35 | 2.7 | 4.11 | |
Income quality | 1.33 | 1.58 | 2.12 | 1.81 | 1.24 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | |
Payout ratio | 0.51 | 0.32 | 0.42 | 0.18 | 0.29 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.07 | 0.08 | 0.08 | 0.08 | 0.06 | |
Intangibles to total assets | 0 | 0 | 0 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.68 | -0.74 | -0.77 | -0.19 | -0.29 | |
Capex to revenue | -0.12 | -0.18 | -0.13 | -0.06 | -0.06 | |
Capex to depreciation | -1.05 | -1.68 | -1.2 | -0.63 | -0.8 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 17.02K | 21.24K | 17.05K | 27.7K | 33.66K | |
ROIC | 0.1 | 0.1 | 0.09 | 0.1 | 0.14 | |
Return on tangible assets | 0.08 | 0.09 | 0.04 | 0.09 | 0.11 | |
Graham Net | 2.75K | 3.14K | 422.17 | 3.22K | 8.92K | |
Working capital | 39.33B | 50.58B | 90.32B | 55.77B | 110.75B | |
Tangible asset value | 121.37B | 134.87B | 141.95B | 136.06B | 195.49B | |
Net current asset value | 38.78B | 46.45B | 53.89B | 52.49B | 108.44B | |
Invested capital | 0.01 | 0.18 | 0.24 | 0.24 | 0 | |
Average receivables | 12.74B | 24.35B | 23.24B | 22.7B | 21.39B | |
Average payables | 1.61B | 3.71B | 3.68B | 4.64B | 5.53B | |
Average inventory | 5.1B | 14.62B | 17.77B | 18.81B | 24.88B | |
Days sales outstanding | 118.21 | 86.16 | 76.38 | 65.74 | 49.37 | |
Days payables outstanding | 25.03 | 25.41 | 16.73 | 31.84 | 21.4 | |
Days of inventory on hand | 79.26 | 115.02 | 87.29 | 109.91 | 124.05 | |
Receivables turnover | 3.09 | 4.24 | 4.78 | 5.55 | 7.39 | |
Payables turnover | 14.59 | 14.36 | 21.82 | 11.46 | 17.06 | |
Inventory turnover | 4.61 | 3.17 | 4.18 | 3.32 | 2.94 | |
ROE | 0.09 | 0.13 | 0.07 | 0.15 | 0.13 | |
Capex per share | -980.53 | -1.86K | -1.57K | -785.06 | -913.92 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.57K | 3.84K | 4.11K | 3.89K | 3.53K | |
Net income per share | -204.14 | 1.18K | 339 | 707 | 312.25 | |
Operating cash flow per share | 977.11 | 78.36 | 526.03 | 1.36K | 1.08K | |
Free cash flow per share | 902.6 | -13.39 | 302.63 | 1.14K | 715.93 | |
Cash per share | 9.92K | 7.14K | 6.77K | 7.31K | 7.72K | |
Book value per share | 15.21K | 16.28K | 18.16K | 18.72K | 19.05K | |
Tangible book value per share | 14.87K | 15.97K | 17.87K | 18.46K | 19.05K | |
Share holders equity per share | 15.21K | 16.28K | 18.16K | 18.72K | 19.05K | |
Interest debt per share | 3.86K | 1.96K | 1.19K | 359.8 | 248.39 | |
Market cap | 253.42B | 216.68B | 343.53B | 372.47B | 336.28B | |
Enterprise value | 198.36B | 168.39B | 286.99B | 302.42B | 258.73B | |
P/E ratio | -33.92 | 4.89 | 26.18 | 12.91 | 25.9 | |
Price to sales ratio | 7.75 | 6 | 8.64 | 9.39 | 9.15 | |
POCF ratio | 28.35 | 294.14 | 67.49 | 26.88 | 30.02 | |
PFCF ratio | 30.69 | -1.72K | 117.31 | 32.08 | 45.19 | |
P/B Ratio | 1.82 | 1.42 | 1.96 | 1.95 | 1.7 | |
PTB ratio | 1.82 | 1.42 | 1.96 | 1.95 | 1.7 | |
EV to sales | 6.07 | 4.66 | 7.22 | 7.63 | 7.04 | |
Enterprise value over EBITDA | 21.43 | 13.87 | 20.3 | 21.46 | 32.67 | |
EV to operating cash flow | 22.19 | 228.58 | 56.38 | 21.82 | 23.1 | |
EV to free cash flow | 24.02 | -1.34K | 98 | 26.05 | 34.77 | |
Earnings yield | -0.01 | 0.05 | 0.01 | 0.02 | 0.01 | |
Free cash flow yield | 0.03 | 0 | 0.01 | 0.03 | 0.02 | |
Debt to equity | 0.24 | 0.11 | 0.04 | 0.01 | 0 | |
Debt to assets | 0.15 | 0.08 | 0.03 | 0.01 | 0 | |
Net debt to EBITDA | -5.95 | -3.98 | -4 | -4.97 | -9.79 | |
Current ratio | 1.66 | 2.35 | 4.14 | 5.38 | 6.65 | |
Interest coverage | 2.99 | 5.07 | 2.49 | 11.59 | 3.13 | |
Income quality | -4.79 | 0.07 | 1.55 | 1.92 | 3.45 | |
Dividend Yield | 0 | 0 | 0.01 | 0.01 | 0 | |
Payout ratio | 0 | 0 | 1.39 | 0.35 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.06 | 0.05 | 0.04 | 0.06 | 0.11 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.08 | -1.17 | -0.42 | -0.16 | -0.34 | |
Capex to revenue | -0.02 | -0.02 | -0.05 | -0.06 | -0.1 | |
Capex to depreciation | -0.23 | -0.3 | -0.78 | -0.79 | -1.35 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 8.36K | 20.78K | 11.77K | 17.26K | 11.57K | |
ROIC | 0.1 | 0.04 | 0.06 | 0.04 | 0.02 | |
Return on tangible assets | -0.01 | 0.05 | 0.02 | 0.03 | 0.01 | |
Graham Net | 3.27K | 4.76K | 6.89K | 7.94K | 8.47K | |
Working capital | 55.77B | 68.11B | 91.3B | 104.79B | 110.75B | |
Tangible asset value | 136.06B | 150.09B | 172.91B | 188.34B | 195.49B | |
Net current asset value | 52.49B | 65.22B | 88.74B | 102.5B | 108.44B | |
Invested capital | 0.24 | 0.11 | 0.04 | 0.01 | 0 | |
Average receivables | 22.51B | 22.91B | 24.15B | 24.76B | 22.73B | |
Average payables | 5.79B | 6.48B | 5.87B | 5.38B | 5.4B | |
Average inventory | 19.38B | 23.75B | 27.49B | 28.29B | 28.28B | |
Days sales outstanding | 61.09 | 58.91 | 55.79 | 56.43 | 50.46 | |
Days payables outstanding | 28.44 | 31.19 | 20.75 | 25.53 | 20.67 | |
Days of inventory on hand | 98.18 | 120.17 | 121.05 | 121.85 | 119.85 | |
Receivables turnover | 1.47 | 1.53 | 1.61 | 1.59 | 1.78 | |
Payables turnover | 3.16 | 2.89 | 4.34 | 3.53 | 4.35 | |
Inventory turnover | 0.92 | 0.75 | 0.74 | 0.74 | 0.75 | |
ROE | -0.01 | 0.07 | 0.02 | 0.04 | 0.02 | |
Capex per share | -74.5 | -91.75 | -223.4 | -220.26 | -361.52 |
200670.KQ Frequently Asked Questions
What is Humedix Co., Ltd. stock symbol ?
Humedix Co., Ltd. is a KR stock and trading under the symbol 200670.KQ
What is Humedix Co., Ltd. stock quote today ?
Humedix Co., Ltd. stock price is $29250 today.
Is Humedix Co., Ltd. stock public?
Yes, Humedix Co., Ltd. is a publicly traded company.